Literature DB >> 12739010

Hyperthermia improves cellular immune response to human hepatocellular carcinoma subsequent to co-culture with tumor lysate pulsed dendritic cells.

Gerd Schueller1, Anton Stift, Josef Friedl, Peter Dubsky, Thomas Bachleitner-Hofmann, Thomas Benkoe, Raimund Jakesz, Michael Gnant.   

Abstract

Dendritic cells play a major role in cellular immunity. The crucial steps of antigen presentation and processing by DCs may be limiting factors for adoptive cellular immunotherapy. Here, we investigated whether hyperthermia of human hepatocellular carcinoma (HCC) cells induces enhanced cytotoxic cellular immune response. Peripheral blood mononuclear cell (PBMC)-derived DCs were pulsed with tumor cell lysate of the human HCC cell line HepG2, which had been heat shocked prior to incubation for 5 h. Subsequent to TNFalpha-induced maturation DCs were co-cultured with autologous CD4+ and/or CD8+ cells, and T cell mediated cytolysis of HepG2 cells was assessed. We observed enhanced CD4+/8+ cellular cytotoxicity against HepG2 cells subsequent to co-culture with the heat shocked tumor lysate pulsed DCs as compared to pulsing DCs with lysate of non-heat shocked tumor cells. The improved cellular immune response can be related to enhanced expression of HSP 70 and 90 in HepG2 cells upon hyperthermia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12739010

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  12 in total

1.  Combination treatment with comprehensive cryoablation and immunotherapy in metastatic hepatocellular cancer.

Authors:  Li-Zhi Niu; Jia-Liang Li; Jian-Ying Zeng; Feng Mu; Meng-Tian Liao; Fei Yao; Li Li; Chun-Yan Liu; Ji-Bing Chen; Jian-Sheng Zuo; Ke-Cheng Xu
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

Review 2.  Hyperthermia as an immunotherapy strategy for cancer.

Authors:  Joseph J Skitzki; Elizabeth A Repasky; Sharon S Evans
Journal:  Curr Opin Investig Drugs       Date:  2009-06

3.  Laser irradiation of ferrous particles for hyperthermia as cancer therapy, a theoretical study.

Authors:  Jigar M Patel; Cahit A Evrensel; Alan Fuchs; Joko Sutrisno
Journal:  Lasers Med Sci       Date:  2014-08-01       Impact factor: 3.161

4.  Percutaneous radiofrequency ablation for treatment of hepatoblastoma recurrence.

Authors:  Jingjing Ye; Qiang Shu; Minju Li; Tian-an Jiang
Journal:  Pediatr Radiol       Date:  2008-06-06

Review 5.  Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma.

Authors:  Vikrant Rai; Joe Abdo; Abdullah N Alsuwaidan; Swati Agrawal; Poonam Sharma; Devendra K Agrawal
Journal:  Mol Cell Biochem       Date:  2017-06-07       Impact factor: 3.842

6.  Adjuvant properties of thermal component of hyperthermia enhanced transdermal immunization: effect on dendritic cells.

Authors:  Neha Joshi; Vikas Duhan; Neelam Lingwal; Sangeeta Bhaskar; Pramod Upadhyay
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

7.  How does ionizing irradiation contribute to the induction of anti-tumor immunity?

Authors:  Yvonne Rubner; Roland Wunderlich; Paul-Friedrich Rühle; Lorenz Kulzer; Nina Werthmöller; Benjamin Frey; Eva-Maria Weiss; Ludwig Keilholz; Rainer Fietkau; Udo S Gaipl
Journal:  Front Oncol       Date:  2012-07-25       Impact factor: 6.244

8.  Stressful presentations: mild cold stress in laboratory mice influences phenotype of dendritic cells in naïve and tumor-bearing mice.

Authors:  Kathleen M Kokolus; Haley M Spangler; Benjamin J Povinelli; Matthew R Farren; Kelvin P Lee; Elizabeth A Repasky
Journal:  Front Immunol       Date:  2014-02-10       Impact factor: 7.561

Review 9.  High-intensity focused ultrasound treatment for advanced pancreatic cancer.

Authors:  Yufeng Zhou
Journal:  Gastroenterol Res Pract       Date:  2014-06-26       Impact factor: 2.260

10.  Screening for immune-potentiating antigens from hepatocellular carcinoma patients after radiofrequency ablation by serum proteomic analysis.

Authors:  Shunli Shen; Hong Peng; Ye Wang; Ming Xu; Manxia Lin; Xiaoyan Xie; Baogang Peng; Ming Kuang
Journal:  BMC Cancer       Date:  2018-01-31       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.